Work

Phase I trial of MK2 inhibitor in combination with mFOLFIRINOX for untreated metastatic pancreatic ductal adenocarcinoma.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps4233

Authors: Moh'd M. Khushman, Patrick Grierson, Nikolaos Trikalinos, Benjamin R. Tan, Olivia Aranha, Rama Suresh, Michael Iglesia, Nikolaos Andreatos, Caron E. Rigden, Jingxia Liu, Kian-Huat Lim

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814587

Cites:

Cited by:

Related to: 10